Ok Biotech Co., Ltd. AI Stock Analysis
Ok Biotech Co., Ltd. (4155) AI Stock Analysis
Ok Biotech Co., Ltd.
(TWSE:4155)
The overall score of 63 reflects a company with a stable balance sheet and strong bullish technical momentum, offset by significant fundamental risks. The most impactful factor is the persistent negative free cash flow, which raises concerns about the sustainability of its capital-intensive operations. Positively, the stock shows robust price momentum above all key moving averages and a reasonable valuation with a low P/E ratio. The company's financial health hinges on its ability to convert investments into profitable growth that generates positive cash flow.
Ok Biotech Co., Ltd. (4155) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.04B
- Dividend Yield
- 1.78%
- Average Volume (3M)
- 576.28K
- Price to Earnings (P/E)
- 10.0
- Beta (1Y)
- 0.04
- Revenue Growth
- -10.90%
- EPS Growth
- ―
- Country
- TW
- Employees
- 62
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Ok Biotech Co., Ltd. Business Overview & Revenue Model
Company Description
OK Biotech Co., Ltd., established in 2006 and based in Hsinchu City, Taiwan, is a global producer and vendor of blood glucose meters. Its product line further encompasses nebulizers, glucometers, blood sugar meters, blood glucose test strips, and per...
Ok Biotech Co., Ltd. Financial Statement Overview
Summary
Financial performance is mixed. The Income Statement (Score: 58) shows improving gross margins but volatile revenue and thin net margins. The Balance Sheet (Score: 65) is stable with manageable leverage, but return on equity is weak. The primary concern is the Cash Flow Statement (Score: 45), which reveals a fifth consecutive year of negative free cash flow due to heavy capital spending, posing a risk if investments don't yield returns.
Income Statement
58NeutralBalance Sheet
65PositiveCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.54B | 1.56B | 1.67B | 1.19B | 1.48B | 1.26B |
| Gross Profit | 478.56M | 429.25M | 275.65M | 196.88M | 344.96M | 186.83M |
| EBITDA | 357.39M | 201.51M | 205.76M | 87.24M | 247.47M | 85.45M |
| Net Income | 242.24M | 82.45M | 93.97M | 2.95M | 143.46M | 31.42M |
Balance Sheet | ||||||
| Total Assets | 3.99B | 3.85B | 3.70B | 3.07B | 3.06B | 2.81B |
| Cash, Cash Equivalents and Short-Term Investments | 382.88M | 327.06M | 290.50M | 365.34M | 636.64M | 644.63M |
| Total Debt | 1.04B | 1.03B | 779.43M | 332.98M | 780.64M | 735.74M |
| Total Liabilities | 1.42B | 1.27B | 1.13B | 672.26M | 1.21B | 1.11B |
| Stockholders Equity | 2.52B | 2.51B | 2.49B | 2.40B | 1.84B | 1.70B |
Cash Flow | ||||||
| Free Cash Flow | 257.46M | -89.57M | -308.81M | -434.15M | -53.72M | -64.57M |
| Operating Cash Flow | 490.95M | 319.57M | 65.90M | 2.93M | 240.53M | 21.90M |
| Investing Cash Flow | -223.08M | -398.50M | -444.93M | -358.38M | -294.23M | -174.46M |
| Financing Cash Flow | -73.85M | 113.04M | 338.02M | 82.06M | 50.27M | 185.69M |
Ok Biotech Co., Ltd. Peers Comparison
Overall Rating
TW:413868Neutral
TW:410667.5Neutral- TW:415563Neutral
TW:178452Neutral
TW:410847Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:4138 | 68Neutral | TWD 2.15B | 15.66 | ― | 7.75% | -1.10% | -16.90% |
| TW:4106 | 68Neutral | TWD 2.36B | 13.20 | ― | 4.28% | 7.96% | 86.06% |
| TW:4155 | 63Neutral | TWD 2.19B | 10.00 | ― | 1.78% | -10.90% | ― |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:1784 | 52Neutral | TWD 2.38B | 40.18 | ― | 1.96% | 5.41% | -19.02% |
| TW:4108 | 47Neutral | TWD 2.06B | -48.44 | ― | ― | 1.10% | 54.83% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4155 | Ok Biotech Co., Ltd. | 16.70 | 1.17 | 7.55% | |
| TW:1784 | Bionet Corp. | 45.10 | -55.92 | -55.36% | |
| TW:4106 | Wellell Inc. | 24.10 | 3.38 | 16.32% | |
| TW:4108 | Phytohealth Corporation | 10.30 | -4.00 | -27.97% | |
| TW:4138 | Dynamic Medical Technologies Inc. | 54.20 | -5.23 | -8.80% | |
| TW:7860 | Teh Seng Pharmaceutical Mfg Co Ltd | 77.80 | 2.28 | 3.01% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026